151 related articles for article (PubMed ID: 31633764)
1. Mutations that increase expression of the EmrAB-TolC efflux pump confer increased resistance to nitroxoline in Escherichia coli.
Puértolas-Balint F; Warsi O; Linkevicius M; Tang PC; Andersson DI
J Antimicrob Chemother; 2020 Feb; 75(2):300-308. PubMed ID: 31633764
[TBL] [Abstract][Full Text] [Related]
2. Fitness trade-offs of multidrug efflux pumps in
Liu Y; Van Horn AM; Pham MTN; Dinh BNN; Chen R; Raphael SDR; Paulino A; Thaker K; Somadder A; Frost DJ; Menke CC; Slimak ZC; Slonczewski JL
Appl Environ Microbiol; 2024 Feb; 90(2):e0209623. PubMed ID: 38289137
[TBL] [Abstract][Full Text] [Related]
3. Experimental Evolution of Escherichia coli K-12 in the Presence of Proton Motive Force (PMF) Uncoupler Carbonyl Cyanide
Griffith JM; Basting PJ; Bischof KM; Wrona EP; Kunka KS; Tancredi AC; Moore JP; Hyman MRL; Slonczewski JL
Appl Environ Microbiol; 2019 Mar; 85(5):. PubMed ID: 30578262
[TBL] [Abstract][Full Text] [Related]
4. Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli.
Praski Alzrigat L; Huseby DL; Brandis G; Hughes D
J Antimicrob Chemother; 2017 Nov; 72(11):3016-3024. PubMed ID: 28962020
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of AcrEF in Quinolone Resistance Development in Escherichia coli When AcrAB-TolC Function Is Impaired.
Zhang CZ; Chang MX; Yang L; Liu YY; Chen PX; Jiang HX
Microb Drug Resist; 2018; 24(1):18-23. PubMed ID: 28520511
[TBL] [Abstract][Full Text] [Related]
6. EmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrAB.
Lomovskaya O; Lewis K; Matin A
J Bacteriol; 1995 May; 177(9):2328-34. PubMed ID: 7730261
[TBL] [Abstract][Full Text] [Related]
7. Resistance/fitness trade-off is a barrier to the evolution of MarR inactivation mutants in Escherichia coli.
Praski Alzrigat L; Huseby DL; Brandis G; Hughes D
J Antimicrob Chemother; 2021 Jan; 76(1):77-83. PubMed ID: 33089314
[TBL] [Abstract][Full Text] [Related]
8. Role for tandem duplication and lon protease in AcrAB-TolC- dependent multiple antibiotic resistance (Mar) in an Escherichia coli mutant without mutations in marRAB or acrRAB.
Nicoloff H; Perreten V; McMurry LM; Levy SB
J Bacteriol; 2006 Jun; 188(12):4413-23. PubMed ID: 16740948
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance pump AcrAB-TolC is required for high-level, Tet(A)-mediated tetracycline resistance in Escherichia coli.
de Cristóbal RE; Vincent PA; Salomón RA
J Antimicrob Chemother; 2006 Jul; 58(1):31-6. PubMed ID: 16687460
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic resistance begets more resistance: chromosomal resistance mutations mitigate fitness costs conferred by multi-resistant clinical plasmids.
Nair RR; Andersson DI; Warsi OM
Microbiol Spectr; 2024 May; 12(5):e0420623. PubMed ID: 38534122
[TBL] [Abstract][Full Text] [Related]
11. TCA and SSRI Antidepressants Exert Selection Pressure for Efflux-Dependent Antibiotic Resistance Mechanisms in Escherichia coli.
Ou J; Elizalde P; Guo HB; Qin H; Tobe BTD; Choy JS
mBio; 2022 Dec; 13(6):e0219122. PubMed ID: 36374097
[TBL] [Abstract][Full Text] [Related]
12. Novel mechanisms of TolC-independent decreased bile-salt susceptibility in Escherichia coli.
Le VVH; Biggs PJ; Wheeler D; Davies IG; Rakonjac J
FEMS Microbiol Lett; 2020 May; 367(10):. PubMed ID: 32407499
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic-sensitive TolC mutants and their suppressors.
Augustus AM; Celaya T; Husain F; Humbard M; Misra R
J Bacteriol; 2004 Mar; 186(6):1851-60. PubMed ID: 14996816
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a putative multidrug resistance pump from Vibrio cholerae.
Colmer JA; Fralick JA; Hamood AN
Mol Microbiol; 1998 Jan; 27(1):63-72. PubMed ID: 9466256
[TBL] [Abstract][Full Text] [Related]
15. The 2019 Garrod Lecture: MDR efflux in Gram-negative bacteria-how understanding resistance led to a new tool for drug discovery.
Piddock LJV
J Antimicrob Chemother; 2019 Nov; 74(11):3128-3134. PubMed ID: 31626705
[TBL] [Abstract][Full Text] [Related]
16. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.
Shigemura K; Tanaka K; Yamamichi F; Shirakawa T; Miyake H; Fujisawa M
Int J Antimicrob Agents; 2012 Dec; 40(6):516-20. PubMed ID: 23068598
[TBL] [Abstract][Full Text] [Related]
17. Unravelling mechanisms of nitrofurantoin resistance and epidemiological characteristics among Escherichia coli clinical isolates.
Zhang X; Zhang Y; Wang F; Wang C; Chen L; Liu H; Lu H; Wen H; Zhou T
Int J Antimicrob Agents; 2018 Aug; 52(2):226-232. PubMed ID: 29753133
[TBL] [Abstract][Full Text] [Related]
18. AcrAB-TolC efflux pump system plays a role in carbapenem non-susceptibility in Escherichia coli.
Chetri S; Bhowmik D; Paul D; Pandey P; Chanda DD; Chakravarty A; Bora D; Bhattacharjee A
BMC Microbiol; 2019 Sep; 19(1):210. PubMed ID: 31488061
[TBL] [Abstract][Full Text] [Related]
19. The Role of AcrAB-TolC Efflux Pumps on Quinolone Resistance of E. coli ST131.
Atac N; Kurt-Azap O; Dolapci I; Yesilkaya A; Ergonul O; Gonen M; Can F
Curr Microbiol; 2018 Dec; 75(12):1661-1666. PubMed ID: 30283991
[TBL] [Abstract][Full Text] [Related]
20. Lon protease inactivation, or translocation of the lon gene, potentiate bacterial evolution to antibiotic resistance.
Nicoloff H; Andersson DI
Mol Microbiol; 2013 Dec; 90(6):1233-48. PubMed ID: 24325250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
